|
Sign In to gain access to subscriptions and/or personal tools.
|
14(2):100-114 (2003) Crit Rev Oral Biol Med
© 2003 International and American Associations for Dental Research
THE BIOCHEMISTRY AND PHYSIOLOGY OF METALLIC FLUORIDE: ACTION, MECHANISM, AND IMPLICATIONS
Liang Li
Faculty of Dentistry, University of Manitoba, 780 Bannatyne Avenue, Winnipeg R3E 0W2 , MB, Canada; umlil{at}cc.umanitoba.ca
Fluoride is a well-known G protein activator. Activation of heterotrimeric GTP-binding proteins by fluoride requires trace amounts of Al3+ or Be2+ ions. AlFx mimics a -phosphate at its transition state in a G protein and is therefore able to inhibit its GTPase activity. AlFx also forms complexes with small GTP-binding proteins in the presence of their GTPase-activating proteins (GAP). As phosphate analogs, AlFx or BeFx affect the activity of a variety of phosphoryl transfer enzymes. Most of these enzymes are fundamentally important in cell signal transduction or energy metabolism. Al3+ and F- tend to form stable complexes in aqueous solution. The exact structure and concentration of AlFx depend on the pH and the amount of F- and Al3+ in the solution. Humans are exposed to both F and Al. It is possible that Al-F complexes may be formed in vivo, or formed in vitro prior to their intake by humans. Al-F complexes may play physiological or pathological roles in bone biology, fluorosis, neurotoxicity, and oral diseases such as dental caries and periodontal disease. The aim of this review is to discuss the basic chemical, biochemical, and toxicological properties of metallic fluoride, to explore its potential physiological and clinical implications.
Key Words: Aluminum fluoride G protein dental bone toxicology physiology clinical implications
Critical Reviews in Oral Biology & Medicine, Vol. 14, No. 2,
100-114 (2003)
DOI: 10.1177/154411130301400204

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Bunda, Y. Wang, T. F. Mitts, P. Liu, S. Arab, M. Arabkhari, and A. Hinek
Aldosterone Stimulates Elastogenesis in Cardiac Fibroblasts via Mineralocorticoid Receptor-independent Action Involving the Consecutive Activation of G{alpha}13, c-Src, the Insulin-like Growth Factor-I Receptor, and Phosphatidylinositol 3-Kinase/Akt
J. Biol. Chem.,
June 12, 2009;
284(24):
16633 - 16647.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. J. McBride, R. M. Sharkey, H. Karacay, C. A. D'Souza, E. A. Rossi, P. Laverman, C.-H. Chang, O. C. Boerman, and D. M. Goldenberg
A Novel Method of 18F Radiolabeling for PET
J. Nucl. Med.,
June 1, 2009;
50(6):
991 - 998.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L.-Q. Ma, C. Liu, F. Wang, N. Xie, J. Gu, H. Fu, J.-H. Wang, F. Cai, J. Liu, and J.-G. Chen
Activation of Phosphatidylinositol-Linked Novel D1 Dopamine Receptors Inhibits High-Voltage-Activated Ca2+ Currents in Primary Cultured Striatal Neurons
J Neurophysiol,
May 1, 2009;
101(5):
2230 - 2238.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. J. Baxter, L. F. Olguin, M. Golicnik, G. Feng, A. M. Hounslow, W. Bermel, G. M. Blackburn, F. Hollfelder, J. P. Waltho, and N. H. Williams
A Trojan horse transition state analogue generated by MgF3- formation in an enzyme active site
PNAS,
October 3, 2006;
103(40):
14732 - 14737.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Frankland, A. Adisa, P. Horrocks, T. F. Taraschi, T. Schneider, S. R. Elliott, S. J. Rogerson, E. Knuepfer, A. F. Cowman, C. I. Newbold, et al.
Delivery of the Malaria Virulence Protein PfEMP1 to the Erythrocyte Surface Requires Cholesterol-Rich Domains
Eukaryot. Cell,
May 1, 2006;
5(5):
849 - 860.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|